VNME SEC filings, in plain English
Everything Vendome Acquisition Corp I has filed with the SEC that we hold — 40 filings, newest first, 38 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: A Schedule 13G/A amendment, classified as a routine SEC compliance exhibit filing a beneficial ownership disclosure. The provided excerpt lists only a filing identifier, the document type, and the reporting entity, Meteora Capital, LLC. It contains no numerical figures or substantive statements. Consequently, it reports nothing bearing on redemption deadlines, trust account valuation, extension mechanisms, business combination progress, or sponsor behavior. It also contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, and therefore attributes no statements to any party. Why it matters: Because the text supplies solely a regulatory header and holder designation without share quantities, transaction intent, or corporate governance details, it presently signals zero shift in the parameters relevant to the July 2027 dissolution window, the documented per-share trust balance, or active deal pursuit. Full evaluation requires reviewing the companion information tables that specify acquired share counts, percentage ownership, and stated purpose of the transaction.
What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2026. No material changes to redemption mechanics, trust value ($10.37 per share, up from $10.20 at year-end), combination period (24 months from July 3, 2025, so deadline is July 3, 2027), or extension provisions. No new business combination agreement or letter of intent disclosed. Operating cash burn ($262,616) and modest working capital ($240,556) remain routine post-IPO. Why it matters: The trust continues to grow through interest income (now ~$3.6M for six months), and the per-share redemption value has risen from $10.20 to $10.37. The deadline is still July 3, 2027, leaving plenty of time. No extension was needed and none is mentioned. The sponsor's $300,000 loan was repaid in July 2025; no working capital loans are outstanding, and the $840,000 convertible note has not been drawn. There are no legal proceedings, no deal rumors, and no insider trading activity reported. The filing is clean but contains no actionable catalyst.
What changed vs 2026-05-14trust $205.6M → $207.4M +1%trust account, mandate language, redeemable shares1 moved · 2 with no prior record of ours
- Trust account
- $205.6M$207.4M
- Mandate language
- focus our search on high potential businesses based in the U… · unchanged
- Redeemable shares
- 20.0M · unchanged
SpacBrain reads this as $1,782,096 was added to the trust between the two filings.
The clause …“that is significant to the fair value measurement. The fair value of the cash held in Trust account of $ 207,384,290 and $ 204,032,946 is measured at Level 1 of the fair value hierarchy at June 30, 2026 and December 31, 2025,”…
The clause …“and contingencies (Note 6) Class A ordinary shares, $ 0.0001 par value; 20,000,000 shares subject to possible redemption as of June 30, 2026 and December 31, 2025 at $ 10.37 and $ 10.20 per share, respectively 207,384,290”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Joint Filing Statement pursuant to Rule 13d-1(k) attached to a Schedule 13G/A beneficial ownership report. FIRST, this document is a signature page and joint filing acknowledgement for a Schedule 13G/A amendment, executed on May 15, 2026. SECOND, regarding redemption deadlines, trust value, extensions, deal progress, and sponsor conduct: the provided text discloses nothing altering these mechanics. It contains no amendments to holdback schedules, no proposed extension votes, no target acquisition updates, and no sponsor voting directives or behavioral disclosures. THIRD, regarding other substantive claims: the exhibit makes no assertions about customers, revenue, market size, strategy, technology, partnerships, litigation, or operational metrics. The only numerical data present is the regulatory year “2026” in the filing ID and the execution date “May 15, 2026”. All executive titles and corporate affiliations (Joy Ausili as Trustee, Vice President, and Assistant Secretary; Chad Eisenberg as Chief Operating Officer) are attributed directly to the exhibit’s signatory blocks. Why it matters: For investors tracking the SPAC’s SEARCHING status, this filing segment formalizes joint reporting liability among First Trust Merger Arbitrage Fund, First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC. By binding all signatories to timeliness and accuracy obligations under Rule 13d-1(k), it ensures any future amendment disclosing threshold crossings, changed investment purpose, or adjusted acquisition dates will carry unified enforcement risk. While the excerpt itself yields no leverage over the 2027-07-03 deadline or $10.37 trust-per-share baseline, it signals continued institutional monitoring of the security through a dedicated arbitrage vehicle. Investors awaiting liquidity events or extension notices should monitor subsequent 13G/A bodies for percentage shifts or intent amendments that could indicate coordinated holder positioning ahead of redemption windows.
What changed: Schedule 13G/A amended beneficial ownership report. Meteora Capital, LLC submitted an amendment to its Schedule 13G disclosure regarding its beneficial interest in VNME. The provided text identifies only the form designation, accession number [0001905106-26-000108], and the holding entity; it does not disclose any updated share counts, percentage ownership, purchase or sale transactions, or statements concerning voting or dispositive power. Why it matters: This routine compliance exhibit allows investors to monitor whether Meteora Capital, LLC has adjusted its ownership position or control posture ahead of VNME's SEARCHING status and 2027-07-03 deadline. Institutional ownership shifts frequently precede capital decisions around redemptions, extension proposals, or business combination approvals. Because the excerpt omits all numerical stakes, cost basis, and investment purpose statements, the filing currently provides no measurable signal regarding redemption exposure at the reported trust/share $10.37, sponsor conduct, or deal progress. No claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel are presented.(flagged for human review)
What changed: Form 10-Q (unaudited quarterly report) for Vendome Acquisition Corp I for the period ended March 31, 2026. Trust account grew to $205,602,194 (up from $204,032,946) due to $1,769,248 interest income, partially offset by a $200,000 withdrawal for working capital. Redemption value per share increased from $10.20 to $10.28. Cash used in operations was $126,489. No business combination or extension announced. Accretion of carrying value to redemption value was $1,569,248, reducing retained earnings. Related party payable increased to $90,000. Why it matters: Confirms the SPAC is still searching, trust value is growing slowly, and cash burn is low. The trust per share at $10.28 provides a modest buffer above the $10.00 IPO price. The absence of any deal announcement, extension, or litigation keeps the focus on the 24-month deadline (July 3, 2027). Investors tracking redemption mechanics and sponsor conduct will note the permitted trust withdrawal and zero working capital loan balance.
What changed vs 2025-11-19trust $202.1M → $205.6M +2%trust account, sponsor loans outstanding, mandate language +11 moved · 3 with no prior record of ours
- Trust account
- $202.1M$205.6M
- Sponsor loans outstanding
- $300Knot matched in this filing
- Mandate language
- focus our search on high potential businesses based in the U… · unchanged
- Redeemable shares
- 20.0M · unchanged
SpacBrain reads this as $3,533,496 was added to the trust between the two filings.
The clause …“that is significant to the fair value measurement. The fair value of the cash held in Trust account of $ 205,602,194 and $ 204,032,946 is measured at Level 1 of the fair value hierarchy at March 31, 2026 and December 31, 2025,”…
The clause …“and contingencies (Note 6) Class A ordinary shares, $ 0.0001 par value; 20,000,000 shares subject to possible redemption as of March 31, 2026 and December 31, 2025 at $ 10.28 and $ 10.20 per share, respectively 205,602,194”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Schedule 13G/A, a routine compliance exhibit updating beneficial ownership disclosure. The excerpt identifies Glazer Capital, LLC and Paul J. Glazer as reporting parties under filing identifier [0001076809-26-000057], but the text supplies zero share counts, ownership percentages, voting authority, or transaction timestamps. Why it matters: Because it functions solely as a post-acquisition or pre-deal holdings notification, the filing contains no directives or data that would impact the July 2027 expiration window, the stated trust account valuation, extension mechanisms, target search progression, or sponsor conduct protocols. Furthermore, per the published language, neither reporting party advances assertions regarding customer pipelines, revenue runrates, total addressable markets, corporate strategy, technology roadmaps, commercial alliances, active litigation, or executive succession.
What changed: 10-K Annual Report for Vendome Acquisition Corporation I (VNME), a blank-check SPAC searching for a business combination. The Company completed its IPO on July 3, 2025, raising $200,000,000 (20,000,000 units at $10.00 per unit). Simultaneously, it sold 2,648,000 private placement warrants for an additional $2,648,000. As of December 31, 2025, $200,000,000 was placed in the trust account, earning $4,032,946 in interest, resulting in a trust value of $204,032,946 as of year-end. The trust redemption value per share is $10.20. Total transaction costs were $2,105,782. The deadline to complete a business combination is 24 months from the IPO closing (July 3, 2027). Why it matters: This is the first annual report following the IPO, providing the base financial condition for investors tracking the trust value, redemption mechanics, and sponsor conduct. The report confirms the trust is funded above the $10.00 threshold at $10.20 per share due to interest income, and that the Club has 24 months (until July 3, 2027) to complete a deal. It details sponsor share structure (5,000,000 founder shares, 20% stake) and the agreements governing sponsor behavior, including that the sponsor has agreed to vote in favor of any business combination and not to propose amendments altering redemption rights without a redemption offer. The report also highlights a unique risk: because of the sponsor’s low cost basis ($0.005 per founder share), the sponsor can profit even if public shares lose value, creating a potential misalignment of incentives.
What changed: Routine compliance exhibit: SEC Schedule 13G beneficial ownership report for VNME filed by Meteora Capital, LLC. The excerpt identifies Meteora Capital, LLC as the reporting entity. It contains no disclosed share quantities, ownership percentages, transaction dates, or statements regarding redemption windows, trust account balances, extension mechanisms, business combination status, or sponsor conduct; therefore, no SPAC mechanics or investor timeline parameters are altered in this text. Why it matters: A Schedule 13G generally signals aggregate, non-controlling beneficial ownership crossing regulatory thresholds. Because the provided excerpt lacks all numerical disclosures, purpose-of-transaction language, and substantive corporate or financial claims, it does not independently impact capital structure, liquidity mechanics, or deal pursuit timelines. Any material information regarding strategy, partnerships, or personnel would reside in the omitted tables and exhibit pages not supplied here.
What changed: A Schedule 13G/A amendment filing submitted to the SEC by Barclays PLC to report changes in beneficial ownership of Vendome Acquisition Corp I securities. The provided excerpt lists only the filer name (Barclays PLC) and the SEC control number. It discloses no share quantities, percentage thresholds, transaction dates, or purchase prices attributed to Barclays PLC or any other entity. Consequently, the text contains no update to redemption mechanisms, the $10.37 trust balance per share, extension votes, business combination milestones, or sponsor conduct. Why it matters: Because the submission is a routine regulatory ownership disclosure, it does not modify the SPAC's $10.37-per-share trust environment, the 2027-07-03 liquidation deadline, or investor redemption options. With no position size, acquisition date, or pricing attributed to Barclays PLC or any counterpart, the filing introduces no material catalyst for deal progress, partnership formation, technological development, or litigation that would alter the current SEARCHING status or trigger sponsorship action.
What changed: Quarterly report (Form 10-Q) for Vendome Acquisition Corp I for the quarterly period ended September 30, 2025, the company's first periodic report since its IPO on July 3, 2025. Trust account value per share increased to $10.10 from the initial $10.00 per unit, with $202,068,698 in trust on $200,000,000 of proceeds, reflecting $2,068,698 of interest income. Net income of $1,820,558 was reported from trust interest, with $248,140 in formation and operating expenses. Founder shares were restructured: on March 25, 2025, 5,544,643 Class B shares were surrendered for cancellation; on May 25, 2025, 1,437,500 new founder shares were issued to the Sponsor for no consideration; and 750,000 shares were forfeited because the underwriter did not exercise the over-allotment option. An additional 75,000 founder shares were transferred to independent director nominees. The Sponsor borrowed $300,000 under an unsecured promissory note, which was repaid on July 22, 2025. A convertible working capital note of up to $840,000 was issued. No business combination has been announced; the deadline remains 24 months from the IPO (July 3, 2027). Why it matters: This filing provides the first post-IPO financial snapshot, confirming the trust account is earning interest and per-share value is slightly above $10.00. The founder share adjustments reflect sponsor alignment and the forfeiture of over-allotment shares. There is no deal progress or extension, but the SPAC is early in its 24-month search window. The filing reaffirms existing redemption mechanics and the absence of any new or adverse sponsor conduct.
trust account, redeemable shares, sponsor loans outstanding +1nothing moved · 4 with no prior record of ours
- Trust account
- not previously extracted$202.1M
- Redeemable shares
- not previously extracted20.0M
- Sponsor loans outstanding
- $300K · unchanged
- Mandate language
- focus our search on high potential businesses based in the U… · unchanged
The clause …“that is significant to the fair value measurement. The fair value of the cash held in Trust account of $ 202,068,698 is measured at Level 1 of the fair value hierarchy at September 30, 2025. Derivative Financial Instruments The Company”…
The clause …“and contingencies (Note 6) Class A ordinary shares, $ 0.0001 par value; 20,000,000 shares subject to possible redemption at $ 10.10 per share 202,068,698 Shareholders’ Equity: Preference shares, $ 0.0001 par value; 1,000,000”…
The clause …“loan the Company up to $ 300,000 . As of September 30, 2025, the Company had borrowed $ 300,000 under such unsecured, non-interest bearing promissory note. The Company repaid the outstanding balance of the note on July 22, 2025.”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Schedule 13G beneficial ownership report identifying Meteora Capital, LLC as a reporting shareholder. According to the filing, Meteora Capital, LLC discloses no adjustments to Vendome Acquisition Corp I’s redemption deadline, trust account per-share balance, extension proposal timeline, business combination search progress, or sponsor conduct. The document records only routine institutional holding disclosure. Why it matters: Schedule 13G submissions allow investors to monitor cumulative institutional positioning ahead of special meeting votes or liquidation triggers. While block accumulation can influence shareholder sentiment during redemption windows or extension debates, this filing contains no projections, valuation references, or governance commitments, providing no direct guidance on capital return timing or deal execution.
What changed: Routine compliance exhibit: Exhibit I (Joint Filing Statement) attached to a Schedule 13G beneficial ownership report. The filing establishes that First Trust Merger Arbitrage Fund, First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC will submit the accompanying Schedule 13G as a single coordinated disclosure. By signing, Joy Ausili (Trustee, Vice President, and Assistant Secretary) and Chad Eisenberg (Chief Operating Officer) accept shared responsibility for the timeliness, completeness, and accuracy of the principal statement. Each party acknowledges individual liability for its own portions and limited liability for the others unless it knows or has reason to believe those portions contain inaccuracies. No provisions alter VNME’s redemption window, trust account balance, extension triggers, merger negotiations, or sponsor governance. Why it matters: For investors tracking redemption deadlines, trust value, extension mechanics, deal progress, or sponsor conduct, this document delivers zero operational signal. It is a procedural aggregation tool mandated by Rule 13d-1(k) to streamline filings across affiliated management vehicles. The text contains no claims regarding customer bases, revenue generation, total addressable market, strategic pivots, proprietary technology, partnership agreements, litigation posture, or executive personnel shifts. The only numerical elements are the execution date (November 14, 2025) and the SEC assignment identifier [0001604488-25-000238]. Because it functions exclusively as an administrative liability waiver and filing conduit, it does not require adjustments to redemption calendars, price-per-share trust models, or voting timelines. Its sole market relevance is confirming that all named First Trust affiliates are contractually bound to the same disclosure envelope, eliminating the risk of staggered or conflicting 13G amendments.
What changed: A Schedule 13G/A beneficial ownership report filed on 2025-11-14 identifying Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., Sculptor Master Fund, Ltd., and Sculptor Special Funding, LP as registered holders of Vendome Acquisition Corp I securities. The filing amends a prior Section 13(d) disclosure to reflect the current holding status of the listed Sculptor affiliates. The provided excerpt contains no share quantities, percentage-of-outstanding thresholds, sole or shared voting/investment authority allocations, or comparative historical data. Regarding SPAC mechanics—specifically the documented $10.37 trust-per-share level, the 2027-07-03 business combination deadline, redemption processing, extension feasibility, or sponsor conduct—the document offers no operational updates, cash-commitment figures, merger timelines, or governance motions. No customer relationships, revenue projections, market sizing, technology roadmaps, partnership announcements, litigation developments, or executive appointments are referenced. Why it matters: For investors tracking liquidation windows and trust preservation, this schedule confirms institutional capital remains registered against the IPO vehicle but provides zero actionable data on redemption pacing, extension voting leverage, or deal-execution readiness. Without explicit beneficial-ownership deltas, stated acquisition purposes, or director/sponsor alignment clauses, the filing neither triggers a liquidity event nor alters the projected path toward the 2027-07-03 milestone. Investors must await definitive proxy materials, Form 8-K disclosures of target searches, or shareholder meeting notices to evaluate how this block may influence vote aggregation, tender dynamics, or potential trust-dilution scenarios.
What changed: A Form 12b-25 Notification of Late Filing submitted by Vendome Acquisition Corporation I regarding its quarterly report on Form 10-Q for the period ended September 30, 2025. The registrant disclosed that the Form 10-Q could not meet the prescribed deadline because the Company and its auditor require additional time to complete the final review of the financial statements and disclosures. The company anticipates filing the report no later than the fifth calendar day following the original due date. Chief Executive Officer and Chief Financial Officer Scott LaPorta certified that all periodic reports required under Sections 13, 15(d), and 30 of the governing Acts over the preceding twelve months were filed on schedule, and that no significant change in results of operations is anticipated. The notification was executed on November 14, 2025. Why it matters: As a routine compliance exhibit, this filing does not reset redemption deadlines, modify trust distribution assumptions, or trigger automatic extension mechanics. Nevertheless, temporary filing pauses delay shareholder access to liquidity metrics, trust interest accumulation, and target diligence updates that directly inform redemptions and sponsor strategy. Per LaPorta, no material operational shift is expected, which contains near-term downside risk. SPAC investors should track whether the final auditor review resolves solely around routine closing procedures or uncovers accounting, internal control, or related-party disclosure items that could necessitate future proxy solicitations, cash preservation measures, or sponsor governance adjustments before the seventh month expires.
What changed: Schedule 13G/A (Amended Beneficial Ownership Report) identifying Vendome Acquisition Sponsor I LLC and Vendome Acquisition Holding I LLC as reporting entities. The provided filing text lists two affiliate holders but contains no share quantities, percentage adjustments, acquisition or disposition details, transaction dates, or explanatory narratives. It does not modify the redemption deadline, extend the business combination period, alter trust account mechanics, or announce deal progress. The excerpt contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, and includes zero numerical data within the text itself. Why it matters: For investors monitoring redemption calendars, trust valuation, extension mechanisms, and sponsor behavior, this filing represents standard regulatory maintenance rather than a catalyst for capital event timing. While the prompt context notes a $10.37 trust per share and a July 3, 2027 expiration, the 13G/A neither adjusts those parameters nor triggers sponsor fiduciary updates tied to deal execution. Absent revised share counts or control changes, the filing confirms ongoing affiliate disclosure without impacting the path to initial or extended business combination completion.
What changed: Schedule 13G — beneficial ownership report. The filing discloses that Glazer Capital, LLC and Paul J. Glazer report beneficial ownership of VNME securities. The text contains no references to adjustments in redemption deadlines, trust share values, extension proposals, deal progress toward a business combination, or alterations to sponsor conduct. Why it matters: Because the document is a Schedule 13G, it indicates passive investment posture rather than an intent to exercise control, which means it does not independently trigger governance changes, force redemption windows open, or signal a shift in how the sponsor manages the search period. Investors tracking Vendome Acquisition Corp I should monitor subsequent amendments to this report for potential shifts in ownership concentration that could eventually intersect with sponsorship dynamics or deadline tolerance.
What changed: a Schedule 13G beneficial ownership report. Based strictly on the provided text citing accession number 0000312069-25-000605, a filing date of 2025-11-12, and holder Barclays PLC, there are no reported changes to the redemption deadline (2027-07-03), the stated trust value ($10.37), extension mechanisms, acquisition progress, or sponsor conduct. The excerpt contains no substantive assertions regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel attributable to Barclays PLC or Vendome Acquisition Corp I. Why it matters: This routine compliance exhibit discloses passive equity accumulation rather than transactional intent. For investors tracking capital structure and timeline milestones, the filing does not alter the 2027-07-03 liquidation window or the $10.37 per-share trust balance, meaning no redemption voting, extension approval, or business combination due diligence steps are triggered by this submission alone. Investors should await subsequent proxy materials or 8-K disclosures for mechanical updates.
What changed: A joint filing agreement attached to a Schedule 13G beneficial ownership report, executed by Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman, designating Hayley Stein as Attorney-in-fact to submit the filing on their behalf pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934. The filing establishes a joint reporting protocol for Schedule 13G submissions covering shares of Vendome Acquisition Corp I, anchored to a statement dated as of September 30, 2025. It discloses zero adjustments to the SPAC redemption timeline, trust account distribution mechanics, extension requests, target search progression, or sponsor governance. The only operational update is the centralization of signature authority through Hayley Stein acting for David J. Snyderman, Administrative Manager of Supernova Management LLC. Why it matters: The exhibit contains no substantive assertions about customer concentration, revenue streams, addressable markets, business strategy, proprietary technology, partnership structures, pending litigation, or executive transitions. The filers do not comment on trust funding levels, voting thresholds, or merger timelines, rendering the document procedurally neutral for investors calibrating redemption windows or evaluating deal catalysts. It matters primarily because it finalizes the reporting chain and confirms the September 30, 2025 snapshot governs the current beneficial ownership disclosure, while leaving all commercial and capital-structure variables unchanged.
What changed: SEC Form 8-K current report and attached press release announcing the commencement of separate trading for Vendome Acquisition Corporation I’s Class A ordinary shares and redeemable warrants. The filing does not modify the redemption calendar, trust account mechanics, extension provisions, or business combination progress. It establishes that, commencing August 22, 2025, holders of units sold in the initial public offering may elect to separately trade the underlying Class A ordinary shares and redeemable warrants. Unseparated units will continue trading under Nasdaq symbol VNMEU, separated shares will trade under VNME, and separated warrants will trade under VNMEW. Each whole warrant carries an exercise price of $11.50 per full share, subject to adjustment. Holders must direct brokers to contact transfer agent Odyssey Transfer and Trust Company to effect the split, and no fractional warrants will be issued. Why it matters: This administrative update alters the trading structure of the SPAC’s capital components but leaves the trust value per share at $10.37 and the July 3, 2027 redemption deadline unaffected. According to the press release attached to the filing, issued by the Company, management intends to focus its acquisition search on the consumer sector operating in North America, Southeast Asia, and Europe. The registration statement for the initial public offering was declared effective by the U.S. Securities and Exchange Commission on June 30, 2025. D. Boral Capital LLC served as the sole book-running manager for the offering, with prospectus copies available through Guarav Verma at 590 Madison Avenue, 39th Floor, New York, New York 10022, or on the SEC website. The report was signed by Chief Executive Officer Scott LaPorta.
What changed: This document is a Joint Filing Agreement (Exhibit 99.1) executed by Vendome Acquisition Sponsor I LLC and Vendome Acquisition Holding I LLC, authorized by Scott LaPorta acting as Authorized Signatory on August 14, 2025, to enable each party to file Schedule 13G statements on behalf of the other regarding their beneficial ownership of Class A ordinary shares, par value of $0.0001 per share, of Vendome Acquisition Corp I. The filing introduces no change to beneficial ownership percentages, aggregate share quantities, acquisition or disposition dates, or cost basis. It does not adjust the SPAC’s redemption calendar, trust account distribution mechanics, extension posture, business combination trajectory, or sponsor behavior beyond the routine execution of this reporting authorization. No dollar amounts related to the trust account, per-share redemption prices, or ownership thresholds are presented. Why it matters: Although it verifies that the sponsor and holding entities continue to consolidate their Section 13(d) reporting obligations under a single joint vehicle, the exhibit yields no forward-looking indicators for shareholders evaluating liquidation risk, tender timelines, or deal execution probability. There are no statements, projections, or disclosures concerning customer contracts, revenue runs, market sizing, strategic roadmap, technological capabilities, partnership pipelines, pending litigation, or management turnover. As a standard Rule 13d-1(k) administrative instrument, it provides zero actionable intelligence on whether Vendome Acquisition Corp I will seek a shareholder vote to extend its search window past August 2027, finalize a merger, or enter default dissolution.
What changed: Quarterly Report on Form 10-Q for the period ended June 30, 2025, filed by a blank check company that had not yet completed its initial public offering as of the balance sheet date. The company consummated its initial public offering on July 3, 2025, subsequent to the quarter end, raising $200 million in gross proceeds and $2.648 million from private placement warrants, creating a trust account of $200 million. The filing also details sponsor share issuances and working capital loans. Why it matters: Confirms IPO terms, trust structure, redemption mechanics, and the 24-month business combination deadline (July 2027). Establishes baseline for shareholders to evaluate progress.
sponsor loans outstanding, mandate languagenothing moved · 2 with no prior record of ours
- Sponsor loans outstanding
- not previously extracted$300K
- Mandate language
- focus our search on high potential businesses based in the U… · unchanged
The clause …“to loan the Company up to $ 300,000 . As of June 30, 2025, the Company had borrowed $ 300,000 under such unsecured, non-interest bearing promissory note. The Company repaid the outstanding balance of the note on July 22, 2025.”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form 10-Q quarterly report. Company consummated its IPO on July 3, 2025, raising $200M gross proceeds, net $200M placed in trust at $10.00 per share, with a 24-month combination period ending July 3, 2027. No business combination announced; still searching. Sponsor holds 5.75M founder shares (20% of post-IPO shares). Why it matters: Establishes the SPAC's trust value, deadline, and sponsor terms. Provides baseline for future redemptions and deal timeline. Confirms SPAC is now public and operational.
What changed: This is a Form 8-K current report accompanied by an audited balance sheet and accompanying financial statement notes, filed on July 10, 2025, to announce the completion of Vendome Acquisition Corporation I’s Initial Public Offering and concurrent private placement on July 3, 2025. On July 3, 2025, the Company completed its IPO of 20,000,000 Units at $10.00 per Unit, generating $200,000,000 in gross proceeds, alongside a private placement of 2,648,000 warrants at $1.00 per warrant producing $2,648,000 in gross proceeds. Management placed $200,000,000 into a trust account administered by Odyssey Transfer and Trust Company, permitting up to 5% of accrued interest to be released for working capital or tax obligations. The charter establishes a fixed 24-month combination period from the IPO closing, setting a July 3, 2027, liquidation deadline. Public shareholders retain redemption rights entitling them to a pro rata trust distribution initially anticipated at $10.00 per share plus interest, subject to a 15% group cap without prior consent if a tender offer is bypassed. Sponsor Vendome Acquisition Sponsor I LLC waived redemption rights on its 5,750,000 founder shares, committed to a $10,000 monthly administrative fee, retains access to a convertible promissory note facility up to $840,000, and pledged a trust indemnification obligation covering third-party claims that reduce the per-share balance below the lesser of $10.00 or the actual trust amount. The July 3, 2025 balance sheet, audited by Adeptus Partners, LLC, discloses $73,592 in operating cash, $352,801 in prepaid expenses, a $1,006,587 due-from-sponsor receivable (settled July 8, 2025), $566,711 in accrued expenses, a $300,000 related party payable, a $300,202 derivative liability tied to the over-allotment option, and $266,067 in total shareholders’ equity. Why it matters: This filing locks the foundational trust architecture, redemption triggers, and sponsor alignment covenants that directly govern future cash-per-share valuation floors, extension viability, and liquidation sequencing. By confirming the $200,000,000 trust anchor and the hard 24-month countdown, investors now possess a deterministic schedule to model interest accretion against permitted working-capital drawdowns, while the sponsor’s indemnity pledge and convertible note backstop define the precise downside protection available to publicholders if target negotiations fail. Outside the trust, management reports a $266,067 working capital position that dictates whether the SPAC can finance due diligence, travel, and transaction structuring before invoking charter extensions or launching follow-on capital raises. President Diana Derycz-Kessler and corporate counsel explicitly attribute execution uncertainty to macroeconomic and geopolitical headwinds—including escalating Russia-Ukraine hostilities, Middle East conflicts, cross-border sanctions, export controls, tariffs, trade wars, and global health epidemics—which introduces variable friction around target discovery, regulatory approvals, and financing closures. Because the entity remains a blank check company with zero operating revenues, the submission contains no customer concentration metrics, product roadmaps, or partnership announcements; instead, it codifies an industry-agnostic, U.S.-targeted merger mandate governed by exchange listing rules requiring an 80% fair market value threshold relative to trust net assets and control-acquisition thresholds under the Investment Company Act of 1940.
What changed: A Schedule 13G beneficial ownership report that registers seven affiliated entities—Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., Sculptor Master Fund, Ltd., and Sculptor Special Funding, LP—as co-reporting persons for their interests in Vendome Acquisition Corp I. The filing excerpt lists only the reporting parties. It contains no amended share quantities, ownership percentages, transaction dates, purchase prices, or statements of purpose. Consequently, it discloses no alterations to redemption calendars, trust distribution mechanics, extension voting procedures, business combination timelines, or sponsor conduct protocols. Why it matters: For investors monitoring SPAC lifecycle mechanics, this filing functions purely as an administrative registry. Because the document attributes no claims regarding customer concentration, revenue streams, market size, strategy, technology, partnerships, litigation, or personnel movements, and because it omits the threshold calculations or acquisition intent statements that typically drive shareholder voting or redemption behavior, it provides no actionable signal for liquidity planning or capital commitment scheduling. Its lack of numerical disclosure or strategic commentary renders it immaterial to near-term capital resolution events.
What changed: An 8-K Current Report filed by Vendome Acquisition Corporation I (VNME) on July 3, 2025, reporting the consummation of its initial public offering (IPO) of 20,000,000 units at $10.00 per unit, the entry into various standard SPAC agreements, the appointment of new directors, and the deposit of $200,000,000 into the trust account. The SPAC completed its IPO on July 3, 2025, raising $200 million in gross proceeds (20,000,000 units at $10.00/unit). Simultaneously, the Sponsor purchased 2,648,000 private placement warrants at $1.00 each for $2,648,000. Net proceeds of $200,000,000 were deposited into the trust account, resulting in an initial trust value of $10.00 per public share. The Company entered into its underwriting, warrant, trust, registration rights, letter, administrative services, indemnification, and working capital note agreements. Three new independent directors (Jonathan Gray, Brian Webber, Brett Wyard) were appointed to the board and its committees. The deadline to complete a business combination is 24 months from the closing (July 3, 2027). The Company has not yet selected a target and states it intends to focus on consumer sector businesses in North America, Southeast Asia, and Europe. Why it matters: This filing establishes the SPAC's capital structure, trust account, and governance framework at the start of its search period. Investors are now able to track the trust value ($10.00 per share initially), the redemption deadline (July 2027), and sponsor conduct (including insider lock-up and voting commitments). Any future business combination or extension will be measured against the baseline set in this IPO filing.
What changed: Prospectus (424B4) for the initial public offering of Vendome Acquisition Corporation I, a blank check company formed to effect a merger or business combination. Filed final prospectus for IPO of 20,000,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one-half warrant. Total gross proceeds $200,000,000 deposited in trust ($10.00 per public share). Trust earns interest, permitted withdrawals limited to 5% of interest. Deadline: 24 months from closing (July 3, 2027). Sponsor holds 5,750,000 founder shares (20% post-IPO), pays nominal $0.0043/share. Private placement of 2,648,000 warrants at $1.00 each to sponsor. Working capital convertible note up to $840,000. Underwriters have 45-day over-allotment option for up to 3,000,000 additional units. Why it matters: Establishes the SPAC's capital structure, trust value, redemption mechanics, dilution from founder shares and warrants, sponsor incentives, and timeline for finding a target. Sets the baseline for all future redemption calculations and deal progress tracking.
What changed: Form 3 initial statement of beneficial ownership (routine compliance exhibit). This document is a Form 3 initial statement of beneficial ownership. As explicitly stated by the filing, there are no non-derivative transactions or holdings reported for Vendome Acquisition Sponsor I LLC (10% owner), Vendome Acquisition Holding I LLC (10% owner), or directors and officers Paul L. Kessler, Diana Derycz Kessler, and Scott A. LaPorta. Because the Form 3 reports zero movement, the sponsor’s promote allocation remains untouched, executive voting power is unchanged, and there is no altered supply overhang that could interact with the SEARCHING status or the 2027-07-03 liquidation deadline. Within the stated $10.37 per share trust environment, this static reporting creates no mechanical friction for future redemptions, extension votes, or warrant conversion math. Aside from confirming these baseline positions, the filing contains no claims about customers, revenue streams, addressable market size, business strategy, proprietary technology, commercial partnerships, active litigation, or personnel restructuring. Why it matters: Investors tracking the redemption calendar and trust preservation can use this zero-transaction Form 3 as a verified ownership floor as of 2025-06-30. The lack of insider accumulation or disposal signals that neither the sponsor nor management has attempted to signal valuation expectations through secondary market activity, leaving the public float and voting weight fully intact ahead of any eventual combination announcement. Though routine, the filing eliminates speculation around hidden block rotations or promote dilution, providing a clean mechanical baseline for modeling extension timelines and trust utilization under the current $10.37 benchmark.
What changed: Form 8-A for registration of certain classes of securities pursuant to Section 12(b) of the Securities Exchange Act of 1934, formally registering Units (each comprising one Class A Ordinary Share and one-half of one redeemable warrant), Class A Ordinary Shares, and whole redeemable warrants for listing on The Nasdaq Stock Market LLC. The filing registers previously described security classes without amending trust mechanics, redemption rights, or the business combination timeline. Chief Executive Officer Scott LaPorta executed the registration on June 30, 2025, confirming the registrant remains in a SEARCHING phase. The document specifies a Class A Ordinary Share par value of $0.0001 per share and sets the whole warrant exercise price at $11.50. No extension proposals, target acquisition announcements, or shareholder voting events are recorded. Why it matters: This administrative listing confirmation preserves the tradability of the unit, share, and warrant classes on Nasdaq while Vendome continues its search for a business combination. Because the filing merely reinforces existing registration terms and incorporates the original prospectus description by reference, it does not adjust investor redemption windows, alter trust account distribution rules, or signal management pivots. Trading infrastructure remains compliant, but the absence of amendment language, financial disclosures, or target criteria indicates no immediate catalysts will impact the July 3, 2027 deadline or trigger mandatory redemption calculations. All structural details originate solely from the registrant’s filing and the incorporated Form S-1 originally submitted April 15, 2025 (File No. 333-286534).
What changed: SEC Form 3 initial statement of beneficial ownership of securities (routine compliance exhibit). Reporting person Jonathan H. Gray, identified as a director, submitted a Form 3 explicitly stating 'No non-derivative transactions or holdings reported.' Insider equity positions remain unaltered. Why it matters: The zero-transaction filing delivers no signal on director share accumulation, which SPAC investors track for alignment with public shareholders, potential underwriting support, or precursor activity to a business combination. It does not affect redemption pricing calculations, trust distribution mechanics, extension voting schedules, or target search deadlines. The document contains no statements regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or additional personnel.
What changed: Form 3 initial statement of beneficial ownership. The reporting person, director Brett G. Wyard, states there are no non-derivative transactions or holdings reported. No amendments to trust account valuations, redemption windows, extension schedules, merger targets, or sponsor conduct are disclosed. Why it matters: This routine compliance exhibit provides no actionable data on capital deployment or insider alignment. Because the SEC filing confirms zero reported equity movement, investors monitoring pre-merger positioning cannot infer sponsorship conviction, warrant leverage adjustments, or impending overhang from director sales. The static disclosure simply satisfies regulatory reporting obligations without altering the mechanical baseline for shareholder redemption decisions or combination timeline risk.
What changed: A Request for Acceleration of the Effective Date of Registration Statement on Form S-1 (SEC CORRESP), filed pursuant to Rule 461 under the Securities Act of 1933. Chief Executive Officer Scott LaPorta requests that the Office of Real Estate & Construction Division of the U.S. Securities and Exchange Commission declare the effective date of File No. 333-286534 to be 9:30 a.m., Eastern Time, on Monday, June 30, 2025. The filing does not amend the redemption calendar, propose an extension past the existing 2027-07-03 deadline, alter the trust value per share of $10.37, or disclose a target. Deal progress remains in the SEARCHING phase. Sponsor conduct reflects routine executive authorization and delegation to outside counsel Paul Hastings LLP (specifically Gil Savir, reachable at (212) 318-6080) to coordinate via telephone once the SEC declares the registration statement effective. Why it matters: Investors tracking redemption deadlines, trust accounting, extensions, deal progress, and sponsor conduct should note that this filing introduces zero new contractual terms, no changes to cash reserve mechanisms, and no adjustments to conversion ratios or pro forma capitalization. The document contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel movements. Because it is a purely procedural acceleration request tied to the existing S-1 registration statement, there is no immediate trigger for the redemption window, no modification to trust distribution schedules, and no update on merger negotiations. The filing confirms the sponsor maintains an active public-market registration pathway, but carries no standalone investment thesis implications until further SEC effectiveness or target-specific disclosures are filed.
What changed: A correspondence letter to the U.S. Securities and Exchange Commission Division of Corporation Finance requesting acceleration of the effective date for Vendome Acquisition Corp I’s Registration Statement on Form S-1. D. Boral Capital LLC joined Vendome Acquisition Corp I in formally requesting SEC action to make the Registration Statement (File No. 333-286534, initially filed April 15, 2025) effective June 30, 2025, at 9:30 a.m., New York time, per the signature page executed by Guarav Verma, Co-Head of Investment Banking. The underwriter confirmed it will take reasonable steps to distribute the preliminary prospectus to dealers, institutions, and others prior to pricing and verified ongoing compliance with Rule 15c2-8. There are no amendments to the trust account value of $10.37 per share, the July 3, 2027 redemption deadline, extension mechanics, or any business combination parameters. Why it matters: The acceleration request advances the sponsor’s capital-raising timeline toward a late-June 2025 listing event, establishing a new regulatory clock for the IPO phase without altering the underlying search period or shareholder redemption rights tied to the original S-1. Legal representation includes Paul Hastings LLP and DLA Piper LLP (US), with Vendome coordination noted through Scott LaPorta. The filing contains no target-specific disclosures, revenue projections, market size estimates, strategic partnerships, or litigation updates beyond standard securities distribution confirmations.
What changed: Amendment No. 3 to Registration Statement on Form S-1 (exhibits-only filing) for Vendome Acquisition Corporation I's initial public offering. Filed final forms of Underwriting Agreement with D. Boral Capital LLC, Amended and Restated Memorandum and Articles of Association, legal opinions of Paul Hastings LLP and Maples and Calder (Cayman) LLP, and Indemnity Agreement. No changes to the narrative portions of the registration statement. Why it matters: Establishes the final terms of the IPO: 20,000,000 units (plus up to 3,000,000 over-allotment) at $10.00 per unit, each unit consisting of one Class A ordinary share and one-half warrant. Trust account to hold $200,000,000 from firm units plus over-allotment proceeds, with $10.00 per public share. Private placement of 2,648,000 warrants at $1.00 each to sponsor. Working capital release of ~$840,000. Deadline for business combination is 24 months from IPO consummation. The governance documents include standard SPAC redemption and extension provisions. The SPAC remains in searching status with no target identified.
What changed: Amendment No. 2 to Form S-1 registration statement for a blank check company's initial public offering, containing a preliminary prospectus detailing the terms of the IPO and the SPAC's structure. Updated offering size from 15,000,000 to 20,000,000 units (plus 3,000,000 over-allotment), reduced private placement warrants from 3,488,000 to 2,648,000, removed deferred underwriting fee, increased over-allotment option shares, and added new exhibits including underwriting agreement, amended charter, warrant agreement, and insider letters. No target business has been selected; the company remains in the searching stage. Why it matters: Provides the final or near-final terms for the SPAC's IPO, including trust mechanics, redemption rights, sponsor compensation with significant dilution potential (founder shares at $0.0043 per share), anti-dilution conversion adjustments, warrant terms, and lock-up provisions. Investors need this to evaluate sponsor incentives, trust value protection, and the timeline for a business combination.
What changed: SEC correspondence (CORRESP) submitting Vendome Acquisition Corp I’s responses to staff comments on Amendment No. 1 to its Form S-1 registration statement. As detailed in the June 23, 2025 filing (File No. 333-286534), the Registrant responded to two SEC Staff comments received June 20, 2025 regarding the June 6, 2025 Amendment No. 1. The SEC Staff first observed that the warrant agreement’s jurisdictional provision applies to federal securities law claims and cited Section 22 of the Securities Act for concurrent federal/state jurisdiction; the Company acknowledged the comment and revised page 81 of Amendment No. 2 and Exhibit 4.4 to clarify applicability to Securities Act claims. Bearing on sponsor conduct and capitalization mechanics, the SEC Staff asked for expanded dilution disclosure under Item 1602(c) of Regulation S-K concerning a Working Capital Convertible Note; the Company states on page 97 that the note may be drawn down at the Company’s discretion and may be converted into Class A ordinary shares at the Sponsor’s option, representing a potential source of future dilution not reflected in the adjusted net tangible book value tables. Why it matters: For investors monitoring redemption deadlines, trust value, and sponsor behavior, the disclosed Working Capital Convertible Note establishes a clear path for the Sponsor to convert borrowed capital into Class A ordinary shares, creating dilution that operates outside the preliminary net tangible book value tables and could impact per-share redemption economics if drawn and converted. The filing leaves the stated $10.37 trust/share and 2027-07-03 business combination deadline unchanged but confirms ongoing regulatory scrutiny and iterative amendment activity. Beyond compliance revisions to the warrant forum and the sponsor-linked convertible note mechanics, the document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, ongoing litigation, or personnel. Correspondence inquiries are routed to Gil Savir of Paul Hastings LLP at 770-878-2696.
What changed: This is an SEC Division of Corporation Finance comment letter addressing Vendome Acquisition Corp I’s Amendment No. 1 to Registration Statement on Form S-1. According to the SEC staff, two specific revisions were required for the amended registration statement: first, the staff noted that a warrant agreement provision applies to federal securities law claims and instructed the company to explicitly state that investors cannot waive compliance with the Securities Act, citing concurrent jurisdiction under Section 22 of the Securities Act, and to revise Exhibit 4.4 to address applicability to Securities Act claims; second, the staff directed expanded narrative disclosure regarding potential future dilution arising from a Working Capital Convertible Note that may be convertible into Class A ordinary shares, referencing Item 1602(c) of Regulation S-K. The letter acknowledges the company’s prior responses and notes that revisions were referenced on page 80 and page 97 of the filing. Why it matters: Per the SEC Division of Corporation Finance, these comments do not alter the SPAC’s operational timeline or force an extension. The directive to detail Working Capital Convertible Note conversion mechanics directly informs how sponsor advances may dilute public shareholders upon a business combination, affecting redemption calculus and post-combination ownership. The warrant jurisdiction clarification adjusts legal remedy pathways without impacting cash positions or trust distributions. The letter was issued by the Office of Real Estate & Construction on June 20, 2025, following review of the Amendment No. 1 filed June 6, 2025, maintaining the current SEARCHING status while deferring registration statement effectiveness until revisions addressing prior May 12, 2025 comments are submitted. Inquiries are assigned to William Demarest (202-551-3432) and Jennifer Monick (202-551-3295) for financial statements, and Pearlyne Paulemon (202-551-8714) and Mary Beth Breslin (202-551-3625) for other matters.
What changed: A Form CORRESP submission responding to U.S. Securities and Exchange Commission staff comments on Vendome Acquisition Corp I’s April 15, 2025 Form S-1 registration statement. In responses directed to the SEC staff, the Registrant confirmed that the amended filing removes the prior stipulation that public shares cannot be redeemed if doing so would cause net tangible assets to fall below $5,000,001 following payment of deferred underwriting commissions. Addressing staff questions on sponsor structure, the Registrant advised that the sponsor is a Cayman Islands limited liability company wholly owned and controlled by U.S. citizens Chief Executive Officer and Chief Financial Officer Scott LaPorta, Executive Chairman Paul Kessler, and President Diana Derycz-Kessler, with no substantial ties to non-U.S. persons. The Registrant also incorporated staff-mandated risk disclosures explaining that CFIUS or other U.S. government reviews could delay or prohibit an initial business combination and require liquidation. Regarding internal allocations, the Registrant told the staff that Amy Wang will no longer serve as an officer and therefore will not receive the 30,000 founder shares initially detailed within a broader transfer of 105,000 founder shares to independent directors and management (distributed as 25,000 shares per independent director and 30,000 shares to Wang). On acquisition strategy, the Registrant expanded dilution narratives to acknowledge staff concerns that the company intends to target businesses with enterprise values of $500 million, which exceeds proceeds from this offering and the sale of private placement warrants, indicating the company may need to issue ordinary shares or convertible equity and debt securities to secure additional financing. Why it matters: Eliminating the $5,000,001 net tangible asset threshold modifies the redemption mechanics, potentially enabling higher shareholder exit rates without triggering a liquidity fallback condition. Clarifying domestic control removes immediate foreign ownership barriers but exposes future targets to mandatory regulatory screening; as the Registrant warns, government delays or prohibitions could extinguish warrant value and force SPAC liquidation. Stating that the intended target valuation of $500 million outpaces available IPO and private placement capital signals imminent reliance on external follow-on financing, which introduces execution uncertainty, third-party approval dependencies, and pro-rata dilution pressure for public shareholders prior to any merger closing. Adjustments to the founder share roster alter insider holding counts without shifting the sponsor’s aggregate voting authority.
What changed: Amendment No. 1 to Registration Statement on Form S-1 for an initial public offering of a blank check company (SPAC), filed to register 20,000,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one-half of one redeemable warrant. Compared to the initial S-1 filing, this amendment increases the offering size from 15,000,000 to 20,000,000 units (23,000,000 if over-allotment exercised in full), decreases private placement warrants from 3,488,000 to 2,648,000, removes the $4.5 million deferred underwriting fee, adds a Working Capital Convertible Note of up to $840,000 issuable to Sponsor, records a $300,000 promissory note from Sponsor, and reflects the transfer of 75,000 founder shares to independent director nominees for no consideration. The financial statements are updated through February 28, 2025, with subsequent events covering these changes. Why it matters: This filing establishes the definitive IPO terms for a new SPAC with $200-$230 million trust capacity, a 24-month deadline to complete a business combination, and significant sponsor compensation (founder shares at ~$0.0043 per share, private warrants at $1.00 each). Investors should note the 20% founder share ownership, the anti-dilution conversion rights, the lack of a minimum redemption threshold, and the ability to amend the charter with a two-thirds vote. The prospectus details redemption mechanics, potential dilution, and conflicts of interest, which are critical for evaluating the SPAC's risk profile.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.